Product category:
Lab automation equipment and robotics
News Release from: Caliper Life Sciences | Subject: Ivis Spectrum
Edited by the Laboratorytalk Editorial
Team on 09 May 2008
Optical imaging to aid tuberculosis
research
Texas A+M Health Science Center Research Foundation (HSCRF) is using Ivis Spectrum imaging system from Caliper Life Sciences to speed development of effective therapeutic treatments for tuberculosis
Research efforts and the purchase of the Ivis system are funded through a grant to the Texas A+M Health Science Center from the Bill and Melinda Gates Foundation Tuberculosis currently affects nearly one-third of the world's population and remains a global threat due to severe and drug-resistant strains
This article was originally published on Laboratorytalk on 4 Sep 2006 at 8.00am (UK)
Related stories
In vivo imaging with fluorescent detection
Ivis spectrum system combines advanced fluorescent and bioluminescent imaging to accelerate preclinical drug discovery and development
Independently control injection into each well
This high-volume liquid handler can independently control delivery of liquids into each well of a 96- or 384-well microplate, through the use of micro-electromechanical systems (Mems)
Liquid handling workstation cuts repetitive tasks
Easy-to-use workstation combines liquid handling and microplate handling processes, enabling researchers to increase walk-away time
According to the World Health Organization, tuberculosis is one of the most serious infectious diseases in the world.
Caliper is dedicated to assisting the global fight against infectious diseases and aiding the discovery of life-saving treatments.
Researchers at the Texas A+M Health Science Center College of Medicine and a consortium of leading tuberculosis researchers at Washington University and Stanford University School of Medicine are actively studying tuberculosis infections in live animals using in vivo imaging technology.
Caliper's Ivis Spectrum was specifically chosen for its highly sensitive luminescence detection and ability to successfully image, track and quantify tuberculosis infections using fluorescence.
The Ivis system enables researchers to visualize the progression of the disease and impact of therapeutic candidates in real time.
This rapid evaluation of in vivo efficacy allows researchers to quickly adapt efforts and progress towards effective treatments for the disease.
"We are quite optimistic that this research collaboration will uncover new and promising discoveries in the fight against tuberculosis," said Kevin Hrusovsky, CEO of Caliper Life Sciences.
"Caliper's imaging technology has proven to be integral in other discovery efforts for finding new ways and treatments to combat infectious disease. Request a free brochure from Caliper Life Sciences ...
"This is a great opportunity to exploit Caliper's imaging technology to make a major impact in this world.".
• Caliper Life Sciences: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
